Makers Laboratories Limited (BOM:506919)

Market Cap	976.81M +14.5%
Revenue (ttm)	1.42B +17.8%
Net Income	23.51M -68.6%
EPS	3.99 -68.6%
Shares Out	5.90M
PE Ratio	41.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,810
Open	164.90
Previous Close	161.30
Day's Range	160.10 - 172.95
52-Week Range	109.00 - 186.70
Beta	0.01
Analysts	n/a
Price Target	n/a
Earnings Date	May 26, 2026

About Makers Laboratories

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, dig...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 131
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506919

Financial Performance

In fiscal year 2026, Makers Laboratories's revenue was 1.42 billion, an increase of 17.85% compared to the previous year's 1.21 billion. Earnings were 23.51 million, a decrease of -68.61%.